Literature DB >> 4291954

Inactivation of adenovirus and simian virus 40 tumorigenicity in hamsters by vaccine processing methods.

G T Truffelli, E A Timm, W B Beardmore, I W McLean.   

Abstract

The effectiveness of the adenovirus vaccine inactivation process in destroying the tumorigenic potential for hamsters of adenoviruses, simian virus 40 (SV-40), and adenovirus-SV-40 hybrids was studied. Baby hamsters injected with untreated virus and with samples subjected to the complete inactivation process and to portions of the process were observed for tumor development for periods in excess of 300 days. Over 20,000 hamsters were injected. From 1 to 7 hr of exposure to formaldehyde at a concentration of 0.031 m at 37 C was sufficient to destroy the tumorigenicity observed in the nontreated preparations. Since the inactivation process included 48 hr of exposure at 37 C to 0.031 m formaldehyde plus treatment with ultraviolet (UV) and with beta-propiolactone (BPL), it was concluded that the process has a large margin of safety. Adenovirus isolates free from tumorigenic potential are difficult, if not impossible, to obtain. Therefore, a proven inactivation process appears to provide the best assurance for obtaining adenovirus vaccines free from such potential. Data presented suggest that the tumorigenic property of the viruses studied might be independent of the infectivity of the preparation. The tumorigenic property was found to be highly susceptible to formaldehyde, but less sensitive to BPL or UV treatment. In contrast, treatment with UV or BPL decreased viral infectivity more readily than tumorigenicity. The three-stage inactivation process (formaldehyde, UV, and BPL) inactivated both tumorigenicity and infectivity.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4291954      PMCID: PMC546958          DOI: 10.1128/am.15.3.516-527.1967

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  32 in total

1.  VIRUS-INDUCED INTRANUCLEAR ANTIGEN IN CELLS TRANSFORMED BY PAPOVAVIRUS SV40.

Authors:  F RAPP; J S BUTEL; J L MELNICK
Journal:  Proc Soc Exp Biol Med       Date:  1964 Aug-Sep

2.  INDUCTION BY ADENOVIRUS TYPE 7 OF TUMORS IN HAMSTERS HAVING THE ANTIGENIC CHARACTERISTICS OF SV40 VIRUS.

Authors:  R J HUEBNER; R M CHANOCK; B A RUBIN; M J CASEY
Journal:  Proc Natl Acad Sci U S A       Date:  1964-12       Impact factor: 11.205

3.  THE INCORPORATION OF SV40 MATERIAL INTO ADENOVIRUS 7 AS MEASURED BY INTRANUCLEAR SYNTHESIS OF SV40 TUMOR ANTIGEN.

Authors:  F RAPP; J L MELNICK; J S BUTEL; T KITAHARA
Journal:  Proc Natl Acad Sci U S A       Date:  1964-12       Impact factor: 11.205

4.  Factors influencing tumor induction in hamsters by vacuolating virus, SV.

Authors:  A J GIRARDI; B H SWEET; M R HILLEMAN
Journal:  Proc Soc Exp Biol Med       Date:  1963-03

5.  Respiratory viruses and respiratory virus vaccines.

Authors:  M R HILLEMAN
Journal:  Am Rev Respir Dis       Date:  1963-02

6.  Identification of the oncogenic substance in rhesus monkey kidney cell culture as simian virus 40.

Authors:  B E EDDY; G S BORMAN; G E GRUBBS; R D YOUNG
Journal:  Virology       Date:  1962-05       Impact factor: 3.616

7.  Experiences in the production of poliovirus vaccines.

Authors:  I W McLEAN; A R TAYLOR
Journal:  Prog Med Virol       Date:  1958

8.  Relative target sizes for the inactivation of the transforming and reproductive abilities of polyoma virus.

Authors:  T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1965-07       Impact factor: 11.205

9.  Tumors induced in hamsters by a strain of adenovirus type 3: sharing of tumor antigens and "neoantigens" with those produced by adenovirus type 7 tumors.

Authors:  R J Huebner; M J Casey; R M Chanock; K Schell
Journal:  Proc Natl Acad Sci U S A       Date:  1965-08       Impact factor: 11.205

10.  IMMUNOFLUORESCENT STUDIES OF ADENOVIRUS 12 TUMORS AND OF CELLS TRANSFORMED OR INFECTED BY ADENOVIRUSES.

Authors:  J H POPE; W P ROWE
Journal:  J Exp Med       Date:  1964-10-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Vaccine development for human mastadenovirus.

Authors:  Shiying Chen; Xingui Tian
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  Analysis of minimal functions of simian virus 40. IV. Oncogenic transformation of syrian hamster kidney cells in vitro by beta-propiolactone inactivated sv40.

Authors:  N H Seemayer; V Defendi
Journal:  Arch Gesamte Virusforsch       Date:  1974

3.  Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.

Authors:  J van der Veen; M F Abarbanel; K G Oei
Journal:  J Hyg (Lond)       Date:  1968-12

4.  Analysis of minimal functions of simian virus 40. II. Enhancement of oncogenic transformation in vitro by UV irradiation.

Authors:  N H Seemayer; V Defendi
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

5.  Oncogenicity of heat-inactivated simian adenovirus SA7.

Authors:  H Soboll; A Fenyves; L Strupp
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.